格隆汇8月18日丨中国银行(03988.HK)公布，2025年7月18日，董事会批准聘任杨军先生为副行长。该行 已收到国家金融监督管理总局核准杨军先生副行长任职资格的批覆。自2025年8月14日起，杨军就任副 行长。 ...

中国银行(03988)公布，2025年7月18日，该行董事会批准聘任杨军先生为该行副行长。该行已收到国家 金融监督管理总局核准杨军先生该行副行长任职资格的批复。自2025年8月14日起，杨军先生就任该行 副行长。 ...

2025 年 7 月 18 日，中国银行股份有限公司（简称"本行"）董事 会批准聘任杨军先生为本行副行长。本行已收到国家金融监督管理总 局核准杨军先生本行副行长任职资格的批复。自 2025 年 8 月 14 日起， 杨军先生就任本行副行长。 杨军先生的简历请见本行 2025 年 7 月 18 日刊登在上海证券交易 所网站（www.sse.com.cn）和本行网站（www.boc.cn）的董事会决议 公告。 特此公告 中国银行股份有限公司董事会 二〇二五年八月十八日 证券代码：601988 证券简称：中国银行 公告编号：临 2025-060 中国银行股份有限公司 关于副行长杨军先生任职的公告 中国银行股份有限公司董事会及全体董事保证本公告内容不存在任何虚 假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 ...

中国银行：已获得国家金融监督管理总局关于杨军担任执行副总裁任职资格的批复。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 楊軍先生的簡歷請見本行2025年7月18日刊登在香港交易及結算所有限公司網站 ( www.hkexnews.hk )和本行網站( www.boc.cn )的董事會決議公告。 公告 本行副行長楊軍先生之委任 2025年7月18日，本行董事會批准聘任楊軍先生為本行副行長。本行已收到國家 金融監督管理總局核准楊軍先生本行副行長任職資格的批覆。自2025年8月14日 起，楊軍先生就任本行副行長。 中國銀行股份有限公司 董事會 中國銀行股份有限公司 BANK OF CHINA LIMITED （於中華人民共和國註冊成立的股份有限公司） （「本行」） （股份代號：3988） 中國，北京 2025年8月18日 於本公告日期，本行董事為葛海蛟、張輝、劉進、張勇*、黃秉華*、劉輝*、師永彥*、樓小惠*、 李子民*、讓•路易•埃克拉 # 、喬瓦尼•特里亞 # 、劉曉蕾 # 、張然 # 、高美懿 # 。 * 非執行董事 # ...

Market Overview - The Hong Kong stock market saw all three major indices rise last week, with the Hang Seng Index increasing by 1.65% to close at 25,270.07 points, the Tech Index rising by 1.52% to 5,543.17 points, and the National Enterprises Index up by 1.62% to 9,039.09 points [1] - In the A-share market, the Shanghai Composite Index rose by 0.83% to 3,696.77 points, the Shenzhen Component Index increased by 1.6% to 11,634.67 points, and the ChiNext Index surged by 2.61% to 2,534.22 points. The total trading volume decreased by 34.597 billion yuan to 2,244.612 billion yuan [2] Pharmaceutical Industry Insights - Chinese pharmaceutical giants, Heng Rui Medicine and Hansoh Pharmaceutical, are expected to report significant profit improvements driven by the launch of innovative drugs and revenue from technology licensing. Heng Rui's net profit for the first half of the year is projected to grow by 40% to 4.1 billion yuan, with revenue increasing by 9% to 15.7 billion yuan. For the full year, profits are expected to rise by 28% to 8.1 billion yuan [3] - Heng Rui is actively optimizing its revenue structure, with the share of generic drug revenue in total revenue dropping from 62% in 2022 to 43% last year, and expected to further decline to 23% by 2027. The company has signed 14 out-licensing agreements since 2018, receiving 600 million USD in upfront payments and potential milestone payments of up to 13.4 billion USD [3] - Hansoh Pharmaceutical is also performing strongly, with a projected net profit increase of over 51% to 2.5 billion yuan for the first half of the year. Its annual profit is expected to grow by 6.2% to 4.64 billion yuan, with innovative drug sales projected to exceed 10 billion yuan, contributing approximately 80% of total revenue, up from 45% in 2021 [3] Banking and Insurance Sector Performance - In the first half of 2025, Chinese commercial banks achieved a cumulative net profit of 1.2 trillion yuan, although profitability indicators showed a slight decline. The average capital return rate was 8.19%, and the average asset return rate was 0.63%, indicating a slowdown in profit growth. However, the banks' risk resistance capacity has improved, with non-performing loans slightly decreasing to 3.4 trillion yuan and the non-performing loan ratio dropping to 1.49% [4] - The insurance industry maintained steady growth in the first half of 2025, with original insurance premium income increasing by 5.1% to 3.7 trillion yuan and the number of new policies rising by 11.1% to 52.4 billion. Despite an increase in claims and payouts, the industry's overall solvency remained robust, with comprehensive and core solvency ratios at 204.5% and 147.8%, respectively [4] - The banking sector has increased support for the real economy, with inclusive loans for small and micro enterprises reaching 36 trillion yuan, a year-on-year growth of 12.3%. Additionally, inclusive agricultural loans increased by 1.1 trillion yuan to 1.39 trillion yuan, reflecting a strong response to policy initiatives [5]

一、核准罗正中国银行股份有限公司北京市分行副行长的任职资格。 三、中国银行应督促上述核准任职资格人员持续学习和掌握经济金融相关法律法规，牢固树立风险合规 意识，熟悉任职岗位职责，忠实勤勉履职。 二、中国银行应要求上述核准任职资格人员严格遵守金融监管总局有关监管规定，自中国银行政许可决 定作出之日起3个月内到任，并按要求及时报告到任情况。未在上述规定期限内到任的，本批复文件失 效，由决定机关办理行政许可注销手续。 2025年8月11日，北京金融监管局发布批复称，《中国银行关于申请核准罗正北京市分行副行长任职资 格的请示》（中银报〔2025〕294号）收悉。经审核，现批复如下： ...

Summary of China Banks Conference Call Industry Overview - The conference call focused on the performance of the China banking sector, particularly the H and A-share banks, which underperformed compared to the broader market indices in July 2025. The MSCI China Banks Index decreased by 3.0%, while the MSCI China Index increased by 7.8% [2][4]. Key Points and Arguments 1. **Performance Discrepancy**: - H-share banks saw ABC-H perform best (flat MoM), while CQRCB-H lagged (-11.3%). For A-share banks, the sector index fell by 3.6%, with ABC being the best performer (+9.9%) and BOBJ the worst (-8.1%) [2][4]. 2. **Weak Credit Growth**: - New RMB loans contracted by RMB 50 billion, which was worse than the expected decline of RMB 15 billion. Household and corporate loans showed significant weakness, with negative prints of RMB 493 billion and RMB 810 billion, respectively [3][4]. 3. **Total Social Financing (TSF)**: - New TSF recorded RMB 1.16 trillion, below the expected RMB 1.4 trillion. Special local government bond issuance was the primary support, totaling RMB 1.24 trillion, which was RMB 556 billion higher YoY [3][4]. 4. **Market Sentiment**: - The underperformance of bank stocks is attributed to a rotation of funds from defensive sectors to growth sectors, driven by expectations of corporate profit recovery and stronger government stimulus [4][5]. 5. **Earnings Expectations**: - As the 2Q25 earnings season approaches, market expectations have cooled, anticipating only a mild improvement in banks' operating trends, which does not support the banks' previous 30% rally year-to-date [4][5]. Investment Outlook 1. **Constructive View on Defensive Stocks**: - Despite near-term weakness, there is an attractive opportunity for high-yield China bank names such as CCB-H, ICBC-H, BOC-H, and CITIC-H, all offering over 5% dividend yield [5][6]. 2. **Medium-Term Support**: - Two positive trends are expected to support China bank stocks: dividend sustainability and a resumption of decent revenue and moderate profit growth from 2026E [5][6]. 3. **Risks and Uncertainties**: - There are significant uncertainties and downside risks to China's macroeconomy and geopolitical landscape, suggesting that defensive sectors like China banks may outperform in the current environment [5][6]. Additional Important Insights - The overall new RMB loan growth has decelerated to 6.9% YoY, while TSF growth slightly accelerated to 8.9% YoY. M2 growth edged up to 8.8% YoY [3][4]. - The analysis indicates that the banking sector's performance is closely tied to macroeconomic indicators and government policies, which will be crucial for future investment decisions [4][5]. This summary encapsulates the key insights from the conference call regarding the performance and outlook of the China banking sector, highlighting both challenges and potential investment opportunities.

Core Viewpoint - China Bank is committed to supporting the private economy in Shanghai by providing tailored financial services that address the unique needs of local enterprises, thereby promoting their growth and international expansion [1][2][3][4]. Group 1: Support for Private Enterprises - China Bank emphasizes its "financial for the people" philosophy, continuously innovating products and services to meet the specific needs of private enterprises in Shanghai [1]. - The bank has developed comprehensive service packages, including guarantees and credit facilities, to assist private companies in overcoming financing barriers and currency risks as they expand internationally [2]. Group 2: Green Transformation Initiatives - The bank is actively supporting the development of a "waste-free city" by providing financial solutions to companies involved in recycling and green initiatives, thus aligning with national green development goals [3]. - China Bank has customized financial service plans that reduce interest costs and waive guarantee fees for enterprises, facilitating their long-term growth and sustainability [3]. Group 3: Market Expansion Support - China Bank is aiding logistics companies in transitioning from labor-intensive to technology-intensive operations by facilitating the issuance of innovative bonds to fund infrastructure and technology development [4]. - The bank has established a collaborative mechanism with local business associations to enhance financing coordination, offering a range of practical measures to support the development of private enterprises [4]. - The bank aims to continuously improve the accessibility and convenience of its financial products and services to foster the prosperity of the private economy [4].

数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，根据天眼查APP-财产线索数据整理，中国银行股份有限公司盘锦分行8月14日发布 《2025年盘锦分行交易银行部国际结算出口单据寄送快递费用项目单一来源结果公示》，详情如下： 标题：2025年盘锦分行交易银行部国际结算出口单据寄送快递费用项目单一来源结果公示 通过天眼查大数据分析，中国银行股份有限公司共对外投资了590家企业，参与招投标项目13274次；财 产线索方面有商标信息1915条，专利信息13023条，著作权信息211条；此外企业还拥有行政许可254 个。 采购方：中国银行股份有限公司盘锦分行 供应商：盘锦新微商务服务有限公司 中标金额：4831.0,4831.00 地区：辽宁省 发布日期：2025-08-14 ...